- 您當(dāng)前的位置:
- 首頁(yè)>
- 產(chǎn)品中心>
- 抗體>
- 重組抗體>
- SARS-CoV-2 Spike RBD...
重組抗體
- SARS-CoV-2 Spike RBD Nanobody
-
恒遠(yuǎn)生物抗體平臺(tái)現(xiàn)已擁有4萬(wàn)多種抗體(含單抗和多抗),包括人類常用抗體,模式生物類相關(guān)抗體、小分子抗體、二抗、標(biāo)簽抗體及內(nèi)參抗體等。并以每年4000種的速度在持續(xù)增長(zhǎng)。
恒遠(yuǎn)生物擁有專業(yè)的質(zhì)控團(tuán)隊(duì),配備先進(jìn)實(shí)驗(yàn)儀器,現(xiàn)已成功地建立了ChIP平臺(tái),因此我們的抗體不僅能提供Biotin、FITC、HRP等標(biāo)記,大部分抗體都能進(jìn)行ELISA、WB、IHC、IF、IP、ChIP等應(yīng)用驗(yàn)證。
我們致力于為所有用戶提供高親和力、高特異性的優(yōu)質(zhì)抗體,歡迎來(lái)電咨詢。
SARS-CoV-2 Spike RBD Nanobody
-
貨號(hào):HYK-200093
-
規(guī)格:
-
圖片:
產(chǎn)品詳情
-
產(chǎn)品描述:
This SARS-CoV-2 S1-RBD (Spike Glycoprotein S1 receptor-binding domain) antibody is a recombinant monoclonal antibody (also a Nanobody) generated through the expression of a DNA sequence inserting a human IgG1 Fc domain at the C-terminus, in human embryonic kidney 293 cells (HEK293). The DNA sequence encodes the SARS-CoV-2 spike RBD. The antibody is purified by protein G in vitro. It has been validated with high reactivity towards SARS-CoV-2 S1-RBD by a functional ELISA and good sensitivity for human SARS-CoV-2 spike glycoprotein (S protein) via the Colloidal Gold Immunochromatography Assay (GICA).
It is also validated in Neutralizing and LSPR. In neu assay, the binding signal of the SARS-CoV-2 S1 RBD antibody was inhibited by ACE2 protein-HRP conjugated inhibitor, with a 0.1074 μg/ml IC50. In LSPR assay, the SARS-CoV-2 S1 RBD antibody showed a high affinity with SARS-CoV-2 Spike protein RBD (affinity constant: 28.2nM).
Specifically binding and recognizing the RBD of the SARS-CoV-2 spike glycoprotein, the SARS-CoV-2 S1 RBD antibody can react with samples infected with human coronavirus SARS-CoV-2. But it does not respond to MERS or SARS-CoV spike protein. Akin to other nanobodies, this recombinant nanobody is small and stable, which allows for its reaching to hidden epitopes such as crevices of target proteins. -
Uniprot No.:P0DTC2
-
別名:Anti-coronavirus spike Antibody; Anti-cov spike Antibody; Anti-ncov RBD Antibody; Anti-ncov S1 Antibody;Anti-ncov spike Antibody; Anti-novel coronavirus RBD Antibody; Anti-novel coronavirus S1 Antibody; Anti-novel coronavirus spike Antibody; Anti-RBD Antibody; Anti-S1 Antibody; Anti-Spike RBD Antibody; E2 Antibody; E2 glycoprotein Antibody; Human coronavirus spike glycoprotein Antibody; S Antibody; SARS-CoV-2 S1 RBD Antibody; S glycoprotein Antibody; Spike glycoprotein Antibody
-
反應(yīng)種屬:Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV)
-
免疫原:Recombinant Human Novel Coronavirus Spike glycoprotein(S) (319-541aa) (CSB-YP3324GMY1 and CSB-MP3324GMY1b1)
-
免疫原種屬:Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV)
-
標(biāo)記方式:Non-conjugated
-
克隆類型:Monoclonal
-
抗體亞型:VHH fusion with human IgG1 Fc
-
純化方式:Affinity-chromatography
-
克隆號(hào):A1
-
濃度:It differs from different batches. Please contact us to confirm it.
-
保存緩沖液:Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 -
產(chǎn)品提供形式:Liquid
-
應(yīng)用范圍:ELISA, GICA, Neutralising
-
推薦稀釋比:
Application Recommended Dilution ELISA 1:10000-1:100000 GICA 1:10000-1:40000 Neutralising 1:100-1:10000 -
Protocols:ELISA Protocol
-
儲(chǔ)存條件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
N Antibody
SARS-CoV-2 Spike RBD Nanobody, HRP conjugated
SARS-CoV-2 Spike RBD Nanobody, FITC conjugated
SARS-CoV-2 Spike RBD Nanobody, Biotin conjugated
Phospho-Histone H3.3 (T3) Antibody
Di-methyl-Histone H3.1(K4)Antibody
在線詢價(jià)
- *
- *
- *
- *
- *
- *
相關(guān)產(chǎn)品
組織胺H4受體抗體
恒遠(yuǎn)生物抗體平臺(tái)現(xiàn)已擁有4萬(wàn)多種抗體(含單抗和多抗),包括人類常用抗體,模式生物類相關(guān)抗體、小分子抗體、二抗、標(biāo)簽抗體及內(nèi)參抗體等。并以每年4000種的速度在持續(xù)增長(zhǎng)。 恒遠(yuǎn)生物擁有專業(yè)的質(zhì)控團(tuán)隊(duì),配備先進(jìn)實(shí)驗(yàn)儀器,現(xiàn)已成功地建立了ChIP平臺(tái),因此我們的抗體不僅能提供Biotin、FITC、HRP等標(biāo)記,大部分抗體都能進(jìn)行ELISA、WB、IHC、IF、IP、ChIP等應(yīng)用驗(yàn)證。 我們致力于為所有用戶提供高親和力、高特異性的優(yōu)質(zhì)抗體,歡迎來(lái)電咨詢。
查看詳細(xì)S Antibody, Biotin conjugated
恒遠(yuǎn)生物抗體平臺(tái)現(xiàn)已擁有4萬(wàn)多種抗體(含單抗和多抗),包括人類常用抗體,模式生物類相關(guān)抗體、小分子抗體、二抗、標(biāo)簽抗體及內(nèi)參抗體等。并以每年4000種的速度在持續(xù)增長(zhǎng)。
查看詳細(xì)Acetyl-Histone H4 (K16) Antibody
恒遠(yuǎn)生物抗體平臺(tái)現(xiàn)已擁有4萬(wàn)多種抗體(含單抗和多抗),包括人類常用抗體,模式生物類相關(guān)抗體、小分子抗體、二抗、標(biāo)簽抗體及內(nèi)參抗體等。并以每年4000種的速度在持續(xù)增長(zhǎng)。
查看詳細(xì)產(chǎn)品中心
最新新聞
- 血清滅活相關(guān)問(wèn)題解答
- 恒遠(yuǎn)生物|七月新增ELISA試劑盒SCI文獻(xiàn),IF總分252.8!
- 恒遠(yuǎn)產(chǎn)品文獻(xiàn):小鼠谷氨酰胺轉(zhuǎn)胺酶2(TGM2)ELISA試劑盒引用文獻(xiàn)
- 2024人免疫球蛋白A2(IgA2)ELISA試劑盒產(chǎn)品說(shuō)明
- 恒遠(yuǎn)生物|六月新增ELISA試劑盒SCI文獻(xiàn),IF總分287.8!
- 關(guān)于抗體的秘密你知道嗎?
- 您的貨物已發(fā)出,請(qǐng)注意查收!
- 流式細(xì)胞術(shù)(FCM)常見(jiàn)問(wèn)題及解答
- 科研筆記丨補(bǔ)體知多少?